Tekcapital have just acquired the exclusive license to a life changing patent application for a non-invasive glucose testing technology. This would completely change the way diabetics monitor their blood sugar levels.
Dermatonics - Heel Balm
The new US patent application from Arizona State University measures glucose levels by using disposable biosensor strips to collect a sample of saliva from humans.
The devices uses the fluid samples for electrochemical analysis. The latest advances with the patent could complete change the way diabetics live their lives, with up to 350m people worldwide suffering from diabetics, this really is a huge breakthrough.
Tekcapital believes that if the technology becomes a success commercially then it has the potential to replaces the need for invasive blood test - which are taken four times a day by diabetics.
A the moment, the method sed by diabetics across the world is to draw a blood sample and place it onto a strip for inception into a medical device. The device then determines the concentration of glucose in the blood, it’s called a glucometer.
The problem with the current method used is that it can cause pain and discomfort for the patient, but more worryingly it can also cause blood-borne infections.
Dr. Clifford Gross, executive chairman of Tekcapital said: “This is a step forward in non-invasive, glucose measurement. If commercialised successfully, this new technology could encourage patients and pet owners to measure blood sugar levels more frequently and without discomfort.”
As the number of diabetics continues to increase and the global population ages, recent research forecast that the diabetes diagnostic market could be worth as much as $14.2bn by 2019.
Thank you for reading the latest news from Dermatonics. If you suffer from diabetes, check out our heel balm!